Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Milano

Showing results (161-170 of 347) with videos related to

Pageof 35
Sort By:
European Journal of Cancer (Oxford, England : 1990)|June 13, 1998
Co-variables influencing 5-fluorouracil clearance during continuous venous infusion. A NONMEM analysisM C Etienne, E Chatelut, X Pivot, et al.
European Journal of Cancer (Oxford, England : 1990)|February 1, 1996
Severe 5-fluorouracil toxicity possibly secondary to dihydropyrimidine dehydrogenase deficiency in a breast cancer patient with osteogenesis imperfectaP Beuzeboc, J Y Pierga, D Stoppa-Lyonnet, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1996
Impact of different fluorouracil biochemical modulators on cellular dihydropyrimidine dehydrogenaseM C Haaz, J L Fischel, P Formento, et al.
British Journal of Cancer|February 23, 1999
Dihydropyrimidine dehydrogenase deficiency and fluorouracil-related toxicityG Milano, M C Etienne, V Pierrefite, et al.
Journal of the National Cancer Institute|August 5, 1992
l-folinic acid versus d,l-folinic acid in rescue of high-dose methotrexate therapy in childrenM C Etienne, A Thyss, Y Bertrand, et al.
Anti-Cancer Drugs|July 8, 2000
Modulation of 5-fluorouracil by 5-ethyl-2'-deoxyuridine on cell lines expressing different dihydropyrimidine dehydrogenase activitiesC Katona, F Tímár, A Jeney, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 23, 2018
Predicting fluoropyrimidine-related toxicity: turning wish to will, the PAMM-EORTC positionJ Ciccolini, M Del Re, R Danesi, et al.
Bulletin Du Cancer|March 26, 2009
[Neoadjuvant approach for non-metastatic rectal cancer combining radiotherapy and chemotherapy. Biotargeted drugs]J-P Gérard, E Francois, E Deustch, et al.
Musculoskeletal Surgery|November 11, 2024
The Italian version of the Majeed pelvic score: translation, cross-cultural adaptation and validationG Vittone, S Cattaneo, C Galante, et al.
Cancer Research|May 15, 1992
Correlation between dihydropyrimidine dehydrogenase activity in peripheral mononuclear cells and systemic clearance of fluorouracil in cancer patientsR A Fleming, G Milano, A Thyss, et al.
Pageof 35

Showing results (161-170 of 347) with videos related to

Sort By:
Pageof 35
European Journal of Cancer (Oxford, England : 1990)|June 13, 1998
Co-variables influencing 5-fluorouracil clearance during continuous venous infusion. A NONMEM analysisM C Etienne, E Chatelut, X Pivot, et al.
European Journal of Cancer (Oxford, England : 1990)|February 1, 1996
Severe 5-fluorouracil toxicity possibly secondary to dihydropyrimidine dehydrogenase deficiency in a breast cancer patient with osteogenesis imperfectaP Beuzeboc, J Y Pierga, D Stoppa-Lyonnet, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1996
Impact of different fluorouracil biochemical modulators on cellular dihydropyrimidine dehydrogenaseM C Haaz, J L Fischel, P Formento, et al.
British Journal of Cancer|February 23, 1999
Dihydropyrimidine dehydrogenase deficiency and fluorouracil-related toxicityG Milano, M C Etienne, V Pierrefite, et al.
Journal of the National Cancer Institute|August 5, 1992
l-folinic acid versus d,l-folinic acid in rescue of high-dose methotrexate therapy in childrenM C Etienne, A Thyss, Y Bertrand, et al.
Anti-Cancer Drugs|July 8, 2000
Modulation of 5-fluorouracil by 5-ethyl-2'-deoxyuridine on cell lines expressing different dihydropyrimidine dehydrogenase activitiesC Katona, F Tímár, A Jeney, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 23, 2018
Predicting fluoropyrimidine-related toxicity: turning wish to will, the PAMM-EORTC positionJ Ciccolini, M Del Re, R Danesi, et al.
Bulletin Du Cancer|March 26, 2009
[Neoadjuvant approach for non-metastatic rectal cancer combining radiotherapy and chemotherapy. Biotargeted drugs]J-P Gérard, E Francois, E Deustch, et al.
Musculoskeletal Surgery|November 11, 2024
The Italian version of the Majeed pelvic score: translation, cross-cultural adaptation and validationG Vittone, S Cattaneo, C Galante, et al.
Cancer Research|May 15, 1992
Correlation between dihydropyrimidine dehydrogenase activity in peripheral mononuclear cells and systemic clearance of fluorouracil in cancer patientsR A Fleming, G Milano, A Thyss, et al.
Pageof 35